Mitochem Therapeutics LLC is categorized under Research and Development Laboratories in Charleston, SC and active since 2010.
Mitochem Therapeutics LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Craig Beeson at the company’s single location by writing to 645 Meeting St # 11, Charleston, South Carolina SC 29403 or by phoning (843) 822-7548. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mitochem Therapeutics LLC |
| Contact Person: | Craig Beeson |
| Address: | 645 Meeting St # 11, Charleston, South Carolina 29403 |
| Phone Number: | (843) 822-7548 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Mitochem Therapeutics LLC was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Craig Beeson for inquiries that concern Mitochem Therapeutics LLC by calling the company number (843) 822-7548, as your correspondence is most welcome. Additionally, the physical location of the single location of Mitochem Therapeutics LLC can be found at the coordinates 32.72963,-79.95529 as well as the street address 645 Meeting St # 11 in Charleston, South Carolina 29403.
For its online presence, you may visit Mitochem Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.